Cleared Special

K062809 - ADMIRAL XTREME PTA CATHETER

K062809 is an FDA 510(k) clearance for ADMIRAL XTREME PTA CATHETER, manufactured by Invatec Innovative Technologies. The device is a Class 2 Cardiovascular device with product code DQY cleared through the Special 510(k) pathway after a 29-day FDA review.

K062809 · Invatec Innovative Technologies · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2006
Decision
29d
Days
Class 2
Risk

K062809 is an FDA 510(k) clearance for the ADMIRAL XTREME PTA CATHETER. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Invatec Innovative Technologies (Plymouth, US). The FDA issued a Cleared decision on October 18, 2006 after a review of 29 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Invatec Innovative Technologies devices

FDA 510(k) Submission Details - K062809

510(k) Number K062809 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 19, 2006
Decision Date October 18, 2006
Days to Decision 29 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
96d faster than avg
Panel avg: 125d · This submission: 29d
Pathway characteristics
Modification to existing cleared device.

DQY Device Classification - Class 2, Special Controls

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 688
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K062809.
ATB ADVANCED PTA DILATATION CATHETER
K063252 · Cook, Inc. · Nov 2006
SELECTSITE C304 DEFLECTABLE CATHETER SYSTEM, MODELS C304-S59, C304-L69, C304-XS59 & C304-XL74
K061416 · Medtronic Vascular · Oct 2006
OCCLUSION BALLOON
K062202 · Boston Scientific Corp · Oct 2006
MODIFICATION TO ANGIODYNAMICS PROFILER PTA BALLOON CATHETER
K062609 · AngioDynamics, Inc. · Oct 2006
MODIFICATION TO POLARCATH PERIPHERAL DILATATION SYSTEM
K062594 · Boston Scientific Corporation · Sep 2006
5F SHERPA ACTIVE NX GUIDE CATHETER
K062420 · Medtronic Vascular · Sep 2006